These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3147914)
1. [Effect of the (Fab')2 fragment of the anti-Pseudomonas aeruginosa antibodies on Pseudomonas-induced keratitis in rats]. Ren PX Yan Ke Xue Bao; 1986 Dec; 2(4):255-7. PubMed ID: 3147914 [No Abstract] [Full Text] [Related]
2. Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma. Welsh NH; Rauch AJ; Gaffin SL Br J Ophthalmol; 1984 Nov; 68(11):828-32. PubMed ID: 6437435 [TBL] [Abstract][Full Text] [Related]
3. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model. Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762 [TBL] [Abstract][Full Text] [Related]
4. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice]. Trautmann M; Brückner O; Hahn H Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study on the immunotherapy for the Pseudomonas keratitis in rabbits (author's transl)]. Tanaka N; Ohzeki T; Tanaka I; Kinoshita N Nippon Ganka Gakkai Zasshi; 1977 Sep; 81(9):1252-9. PubMed ID: 415535 [No Abstract] [Full Text] [Related]
9. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns. Neely AN; Holder IA Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788 [No Abstract] [Full Text] [Related]
10. [Use of hyperimmune anti-Pseudomonas plasma in the treatment of infectious complications]. Grishina IA; Terekhova RP; Marchuk AI; Elagina LV; Ostrovskaia EV; Nezhlukto AIa Khirurgiia (Mosk); 1990 Nov; (11):121-3. PubMed ID: 2127294 [No Abstract] [Full Text] [Related]
11. The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model. Uwaydat S; Jha P; Tytarenko R; Brown H; Wiggins M; Bora PS; Bora NS Curr Eye Res; 2011 Sep; 36(9):787-96. PubMed ID: 21812661 [TBL] [Abstract][Full Text] [Related]
12. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats. Thakur A; Kyd J; Xue M; Willcox MD; Cripps A Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination]. Minukhin VV; Tsyganenko AIa Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161 [TBL] [Abstract][Full Text] [Related]
14. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model. Imamura Y; Yanagihara K; Fukuda Y; Kaneko Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Sawa T; Wiener-Kronish JP; Kohno S Eur Respir J; 2007 May; 29(5):965-8. PubMed ID: 17301098 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice. Moriyama K; Wiener-Kronish JP; Sawa T Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258 [TBL] [Abstract][Full Text] [Related]
16. [Use of pseudomonas immunoglobulin. Indications and results]. Werdan K; Melnitzki S; Pilz G; Reuschel-Janetschek E Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa. Vaccines and immunotherapy. Pennington JE Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838 [TBL] [Abstract][Full Text] [Related]
18. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa]. Nazarchuk LV Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409 [TBL] [Abstract][Full Text] [Related]